Correction to: Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy.

Journal

Journal of experimental & clinical cancer research : CR
ISSN: 1756-9966
Titre abrégé: J Exp Clin Cancer Res
Pays: England
ID NLM: 8308647

Informations de publication

Date de publication:
23 Aug 2019
Historique:
entrez: 25 8 2019
pubmed: 25 8 2019
medline: 25 8 2019
Statut: epublish

Résumé

In the original publication of this article [1], there is an error in Fig. 4A.

Identifiants

DOI: 10.1186/s13046-019-1381-y PMID: 31443669 PMC: PMC6706875
pubmed: 31443669
doi: 10.1186/s13046-019-1381-y
pii: 10.1186/s13046-019-1381-y
pmc: PMC6706875
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

374

Commentaires et corrections

Type : ErratumFor

Références

J Exp Clin Cancer Res. 2019 Feb 8;38(1):63
pubmed: 30736824

Auteurs

Jia Wei (J)

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene Street, Baltimore, MD, 21201, USA.

Ling Ma (L)

Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene Street, Baltimore, MD, 21201, USA.

Yi-Hui Lai (YH)

, 33 Linsen Road, Chungshan District, Taipei, Taiwan.

Ruijie Zhang (R)

Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene Street, Baltimore, MD, 21201, USA.

Huameng Li (H)

Biophysics Graduate Program, The Ohio State University, Columbus, OH, 43210, USA.

Chenglong Li (C)

College of Pharmacy, University of Florida, Gainesville, FL, 32610, USA.

Jiayuh Lin (J)

Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene Street, Baltimore, MD, 21201, USA. JLin@som.umaryland.edu.

Classifications MeSH